Home Applications 022527 Application 022527
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 GILENYA FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.5MG BASE Yes Yes 002 GILENYA FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL EQ 0.25MG BASE Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022527-001 GILENYA FINGOLIMOD HYDROCHLORIDE EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 N022527-002 GILENYA FINGOLIMOD HYDROCHLORIDE EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022527-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022527-001 10543179 2027-12-25 U-2719 2020-01-28 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 N022527-002 9592208*PED 2032-09-30 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL AB RLD 2018-05-11 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL AB RLD 2018-05-11 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL AB RLD 2018-05-11 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL RLD, RS 2010-09-21 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL RLD 2018-05-11 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022527-001 GILENYA EQ 0.5MG BASE CAPSULE / ORAL AB RLD, RS 2010-09-21 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N022527-002 GILENYA EQ 0.25MG BASE CAPSULE / ORAL AB RLD 2018-05-11 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
Observed Orange Book patent history# Patent history page 1 of 8 · 287 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022527-002 9592208*PED 2032-09-30 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022527-002 9592208*PED 2032-09-30 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022527-002 9592208*PED 2032-09-30 Pediatric extension 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022527-002 9592208*PED 2032-09-30 Pediatric extension 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022527-002 9592208*PED 2032-09-30 Pediatric extension fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-001 8324283 2026-03-29 Drug product 2013-01-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-001 8324283*PED 2026-09-29 Pediatric extension b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-001 9187405 2027-06-25 U-2613 2015-12-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-001 9187405*PED 2027-12-25 Pediatric extension b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022527-002 9592208*PED 2032-09-30 Pediatric extension b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-001 8324283 2026-03-29 Drug product 2013-01-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-001 8324283*PED 2026-09-29 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-001 9187405 2027-06-25 U-2613 2015-12-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-001 9187405*PED 2027-12-25 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022527-002 9592208*PED 2032-09-30 Pediatric extension 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-001 8324283 2026-03-29 Drug product 2013-01-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-001 8324283*PED 2026-09-29 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-001 9187405 2027-06-25 U-2613 2015-12-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-001 9187405*PED 2027-12-25 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-002 9592208 2032-03-30 U-2315 Drug product 2018-06-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022527-002 9592208*PED 2032-09-30 Pediatric extension 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022527-001 8324283 2026-03-29 Drug product 2013-01-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022527-001 8324283*PED 2026-09-29 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022527-001 9187405 2027-06-25 U-2613 2015-12-02 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022527-001 10543179 2027-12-25 U-2719 2020-01-28 5bbf6a4d5a75…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 16 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0078-0607 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0607 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0607 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0607 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0607 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0607 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0607 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0607 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0965 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0965 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0965 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0965 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0965 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0965 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0965 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current 0078-0965 Gilenya Fingolimod hcl Novartis Pharmaceuticals Corporation NDA Current